PR Newswire

The newsfeed available here is provided by our content partner PR Newswire. This is one of the most important and widest-reaching press services, providing news, press releases and multimedia content to the media, journalists and the public.
The NewsWire Hub ("X-Billboard") currently comprises four of the most important international news sources and is supplemented by a stock market information service. The individual newswire services complement each other and provide a complementary range of information, more than three quarters of the official news sources on which editors worldwide base their stock market reporting. Your advantage: You will find everything here in one overview. You can navigate to the individual sections using the control elements. In the terminal view, you can carry out individual searches at company level.
presented by
N
More Tools & Gadgets
F&G: 75
6.398,93 S&P · 17,93 Vola-Index · 118.320,21 BTC · 1,17419 EURUSD
System-State: Number of processed items 113.744 Notifications successully processed since Inception
EXCHANGE NEWSBOARD
                              
NEWSWIRE INFOBOARD
                              
PR Newswire is an important news source that can be accessed via the X-Billboard. It is part of the Newswire Hub, which bundles important international news sources for stock market participants in one central location. If you want to get a quick overview, you can easily scroll through the headlines. If you want to look at the news in more detail, you can use the detailed views of the info cards to directly access the respective news item and other analysis tools.
NEWS
EXPLORER
State: 27.07.2025 | 9AM
Mon, 07.04.2025       InnoCan Pharma
CA45783P1027

Innovative Chronic Pain Treatment expand IP Protection in China's US$163 Billion Pharmaceutical Market

HERZLIYA, Israel and CALGARY, AB, April 7, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that a divisional application for its Chinese (CN) liposome-based CBD technology patent was filed.

Following the recently granted patent in India for a prolonged-release pharmaceutical formulation using liposomes to encapsulate CBD, Innocan is actively advancing its efforts to strengthen intellectual property protection across additional Asian markets. China, the second-largest pharmaceutical market in the world, was valued with US $163Bn medicine spending at 2023 (IQVIA). The filing of this divisional application in China reflects the expertise and commitment of the Innocan team and represents a strategic step in aligning the company's intellectual property portfolio with its long-term global business objectives.

Read More
InnoCan Pharma
Technical Analysis Termsheet Terminal
Permalink
CubeSmart
Precision Global Corporation Partners with CubeSmart to Manage Four Strategic Storage Facilities Across Texas
© PR Newswire
Rocket Pharmaceuticals
RCKT Investors Have Opportunity to Lead Rocket Pharmaceuticals, Inc. Securities Fraud Lawsuit
© PR Newswire
Biohaven
BHVN Investors Have Opportunity to Lead Biohaven Ltd. Securities Fraud Lawsuit
© PR Newswire
Neogen
NEOG INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Neogen Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
© PR Newswire
National Grid
Rosen Law Firm Encourages National Grid plc Investors to Inquire About Securities Class Action Investigation - NGG
© PR Newswire
Vestis
VSTS Deadline: VSTS Investors with Losses in Excess of $100K Have Opportunity to Lead Vestis Corporation Securities Fraud Lawsuit
© PR Newswire
Neogen
NEOGEN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Neogen Corporation - NEOG
© PR Newswire
Tempus AI
TEMPUS AI SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Tempus AI, Inc. - TEM
© PR Newswire
Hims & Hers Health
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
© PR Newswire
Reckitt Benckiser
RECKITT BENCKISER SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Reckitt Benckiser Group PLC - RBGLY
© PR Newswire
Mercury General
Mercury Insurance Preparing Homeowners Insurance Rate Filing that Will Broaden Coverage Availability for California Consumers
© PR Newswire
Klotho Neurosciences
UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology
© PR Newswire
Ecopetrol
Ecopetrol Announces Changes in Senior Management
© PR Newswire
Regional Health Properties
Black Pearl Equities, LLC Announces Tender Offer to Purchase Shares of Regional Health Properties, Inc.
© PR Newswire
Luminar Technologies
LAZR Investors Have Opportunity to Lead Luminar Technologies, Inc. Securities Fraud Lawsuit
© PR Newswire
Tungray Technologies
Rosen Law Firm Encourages Tungray Technologies Inc Investors to Inquire About Securities Class Action Investigation - TRSG
© PR Newswire
Semler Scientific
Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Inquire About Securities Class Action Investigation - SMLR
© PR Newswire
Nutex Health
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Nutex Health Inc. (NASDAQ: NUTX) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
© PR Newswire
Travelzoo
Club Offers Released on July 25, 2025
© PR Newswire
City Office REIT
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: TCBC, CIO, TTNP, and VBTX
© PR Newswire
Cantor EPI (SPAC)
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: TLGYF, EFIN, CEPO, and SQCF
© PR Newswire
CARGO Therapeutics
URGENT: The M&A Class Action Firm Launches Legal Inquiry for the Merger - CRGX, HSON, BRZH, and ENZB
© PR Newswire
Olo
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger: KLG, CAPN, OLO, and WAT
© PR Newswire
Liveperson
LivePerson Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
© PR Newswire
Nabors Industries
Nabors Appoints David Tudor as a Director
© PR Newswire

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire cross-link panel at the top allows you to quickly and easily access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted searches.

On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.